Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Kedudukan dalam Saham #40615
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Harga Saham
$0.13607016
Disegerakkan terakhir: 2024-09-10
Modal Pasaran
$112.29K
Perubahan (1 hari)
22.46%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan BiVictriX Therapeutics Plc (BVX)

Kategori

Harga BVX dengan permodalan pasaran b
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
BVX
$0.13607016
Modal pasaran bagi BiVictriX Therapeutics Plc(BVX)
Modal Pasaran: $112.29K
Sehingga August 2026, BiVictriX Therapeutics Plc mempunyai modal pasaran sebanyak $112.29K. Ini menjadikan BiVictriX Therapeutics Plc syarikat ke-40615th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran BiVictriX Therapeutics Plc dari 2021 hingga 2026
BVX berbanding dengan 5 teratas yang paling popular stocks
Harga BVX Aset B Pasaran B Hasilnya
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$6,623,006 $112.29K
$5.466T +4,867,346,307.19%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,399,500 $112.29K
$4.456T +3,968,173,637.66%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,058,556 $112.29K
$4.175T +3,717,608,716.22%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$4,468,567 $112.29K
$3.688T +3,284,016,629.46%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$3,471,163 $112.29K
$2.865T +2,551,009,819.51%